AML cells represented all major morphologic and molecular subtypes including the FLT3-ITD and FLT3 wild type, NPM1 mutant and wild type, and TP53 mutant and wild type AML cell lines as well as a variety of patient-derived AML cells. This evidence concerns the gene FLT3 and acute myeloid leukemia.